肝機能不全(Hepatic Insufficiency):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatic Insufficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hepatic Insufficiency 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
Puma Biotechnology, Inc. 34
Clinical Trial Overview of Puma Biotechnology, Inc. 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
C. H. Boehringer Sohn AG & Co. KG 37
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
Astellas Pharma Europe Ltd. 40
Clinical Trial Overview of Astellas Pharma Europe Ltd. 40
Clinical Trial Overview of Top Institutes / Government 41
Copenhagen University Hospital Gentofte 41
Clinical Trial Overview of Copenhagen University Hospital Gentofte 41
National Cancer Institute 42
Clinical Trial Overview of National Cancer Institute 42
Aarhus University 43
Clinical Trial Overview of Aarhus University 43
Donau-Universitat Krems 44
Clinical Trial Overview of Donau-Universitat Krems 44
Huashan Hospital 45
Clinical Trial Overview of Huashan Hospital 45
Mayo Clinic 46
Clinical Trial Overview of Mayo Clinic 46
McGill University Health Center 47
Clinical Trial Overview of McGill University Health Center 47
Five Key Clinical Profiles 48
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75


【レポート販売概要】

■ タイトル:肝機能不全(Hepatic Insufficiency):世界の治験レビュー(2015年上半期版)
■ 英文:Hepatic Insufficiency Global Clinical Trials Review, H1, 2015
■ 発行日:2015年4月27日
■ 調査会社:GlobalData
■ 商品コード:GDHC2642CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。